Hypopharyngeal Carcinoma: Clinical Trials

1 trial for Hypopharyngeal Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Hypopharyngeal Carcinoma: new trials by email Literature Review of Hypopharyngeal Carcinoma trials Research Report on Hypopharyngeal Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
Neoadjuvant Chemotherapy (NACT), Neoadjuvant and maintenance Tislelizumab, Concurrent chemo-radiotherapy (CCRT) - Laryngeal Carcinoma, Hypopharyngeal Carcinoma
Phase 3Not yet recruitingFudan University1682025-04-282025-05-08

Narrower conditions

Head and Neck Neoplasms (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Laryngeal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pharyngeal Diseases (1)  ·  Pharyngeal Neoplasms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Stomatognathic Diseases (1)

Interventions

Adjuvants, Pharmaceutic (1)  ·  Neoadjuvant Therapy (1)  ·  Surgical Procedures, Operative (1)

Sponsors

Fudan University (1)

Countries

China (1)

Top investigators

Yu Wang, M.D., professor, Chief (1)